| __timestamp | Dr. Reddy's Laboratories Limited | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 94231000 |
| Thursday, January 1, 2015 | 17449000000 | 146394000 |
| Friday, January 1, 2016 | 17834000000 | 188272000 |
| Sunday, January 1, 2017 | 19551000000 | 166707000 |
| Monday, January 1, 2018 | 18265000000 | 401843000 |
| Tuesday, January 1, 2019 | 15607000000 | 560909000 |
| Wednesday, January 1, 2020 | 15410000000 | 722343000 |
| Friday, January 1, 2021 | 16541000000 | 771182000 |
| Saturday, January 1, 2022 | 17482000000 | 877090000 |
| Sunday, January 1, 2023 | 19381000000 | 877387000 |
| Monday, January 1, 2024 | 22873000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) budgets are a testament to a company's commitment to innovation. Dr. Reddy's Laboratories Limited, a stalwart in the industry, has consistently outpaced Sarepta Therapeutics, Inc. in R&D spending over the past decade. From 2014 to 2023, Dr. Reddy's R&D expenses have surged by approximately 85%, peaking in 2023. In contrast, Sarepta's R&D budget, while growing, remains a fraction of Dr. Reddy's, with a notable increase of around 830% from 2014 to 2023. This disparity highlights Dr. Reddy's robust investment in innovation, while Sarepta's focused approach reflects its niche market strategy. As we look to the future, the missing data for 2024 suggests a potential shift in strategy or reporting, leaving industry watchers eager for updates.
R&D Spending Showdown: Novartis AG vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Amgen Inc. and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Gilead Sciences, Inc. vs Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs ImmunityBio, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and MorphoSys AG
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Mesoblast Limited